These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 19910702

  • 1. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury.
    Wang Z, Wei X, Zhang Y, Ma X, Li B, Zhang S, Du P, Zhang X, Yi F.
    Cell Physiol Biochem; 2009; 24(5-6):619-26. PubMed ID: 19910702
    [Abstract] [Full Text] [Related]

  • 2. Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species.
    Kim EY, Anderson M, Dryer SE.
    Am J Physiol Renal Physiol; 2012 Feb 01; 302(3):F298-307. PubMed ID: 22031853
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R, Ferrè S, Hoenderop JG, Dijkman HB, Berden JH, Bindels RJ, Wetzels JF, van der Vlag J, Nijenhuis T.
    Am J Pathol; 2013 Apr 01; 182(4):1196-204. PubMed ID: 23385000
    [Abstract] [Full Text] [Related]

  • 4. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L, Jirka G, Rosenberg PB, Buckley AF, Gomez JA, Fields TA, Winn MP, Spurney RF.
    J Clin Invest; 2015 May 01; 125(5):1913-26. PubMed ID: 25844902
    [Abstract] [Full Text] [Related]

  • 5. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T, Ambrus L, Zákány N, Balla G, Bíró T.
    Acta Physiol Hung; 2015 Sep 01; 102(3):241-51. PubMed ID: 26551740
    [Abstract] [Full Text] [Related]

  • 6. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV, Blass G, Palygin O, Levchenko V, Pavlov TS, Grzybowski MN, Winsor K, Shuyskiy LS, Geurts AM, Cowley AW, Birnbaumer L, Staruschenko A.
    J Am Soc Nephrol; 2018 Jul 01; 29(7):1917-1927. PubMed ID: 29793963
    [Abstract] [Full Text] [Related]

  • 7. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT, Sonneveld R, Bakker-van Bebber M, Wetzels JFM, van der Vlag J, Nijenhuis T.
    J Am Soc Nephrol; 2018 Aug 01; 29(8):2099-2109. PubMed ID: 29954830
    [Abstract] [Full Text] [Related]

  • 8. Sialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats.
    Pawluczyk IZ, Najafabadi MG, Brown JR, Bevington A, Topham PS.
    Lab Invest; 2015 Sep 01; 95(9):1019-28. PubMed ID: 26121320
    [Abstract] [Full Text] [Related]

  • 9. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
    Eid S, Boutary S, Braych K, Sabra R, Massaad C, Hamdy A, Rashid A, Moodad S, Block K, Gorin Y, Abboud HE, Eid AA.
    Antioxid Redox Signal; 2016 Nov 01; 25(13):703-719. PubMed ID: 27393154
    [Abstract] [Full Text] [Related]

  • 10. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD, Singh G, Altintas MM, Yu H, Fernandez IC, Gu C, Wilson C, Srivastava SK, Dietrich A, Walz K, Kerjaschki D, Ruiz P, Dryer S, Sever S, Dinda AK, Faul C, Reiser J.
    J Biol Chem; 2013 Dec 20; 288(51):36598-609. PubMed ID: 24194522
    [Abstract] [Full Text] [Related]

  • 11. NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of podocin in formation of this complex.
    Kim EY, Anderson M, Wilson C, Hagmann H, Benzing T, Dryer SE.
    Am J Physiol Cell Physiol; 2013 Nov 01; 305(9):C960-71. PubMed ID: 23948707
    [Abstract] [Full Text] [Related]

  • 12. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV, Staruschenko A.
    Am J Physiol Renal Physiol; 2015 Sep 01; 309(5):F393-7. PubMed ID: 26084930
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T, Sloan AJ, Hoenderop JG, Flesche J, van Goor H, Kistler AD, Bakker M, Bindels RJ, de Boer RA, Möller CC, Hamming I, Navis G, Wetzels JF, Berden JH, Reiser J, Faul C, van der Vlag J.
    Am J Pathol; 2011 Oct 01; 179(4):1719-32. PubMed ID: 21839714
    [Abstract] [Full Text] [Related]

  • 14. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA, Hwang JC, Guh JY, Chang JM, Lai YH, Chen HC.
    J Lab Clin Med; 2006 Feb 01; 147(2):74-82. PubMed ID: 16459165
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms underlying modulation of podocyte TRPC6 channels by suPAR: Role of NADPH oxidases and Src family tyrosine kinases.
    Kim EY, Hassanzadeh Khayyat N, Dryer SE.
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct 01; 1864(10):3527-3536. PubMed ID: 30293571
    [Abstract] [Full Text] [Related]

  • 16. Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
    Kawamorita Y, Shiraishi T, Tamura Y, Kumagai T, Shibata S, Fujigaki Y, Hosoyamada M, Nakagawa T, Uchida S.
    Physiol Rep; 2017 Aug 01; 5(15):. PubMed ID: 28774949
    [Abstract] [Full Text] [Related]

  • 17. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
    Roshanravan H, Dryer SE.
    Am J Physiol Renal Physiol; 2014 May 01; 306(9):F1088-97. PubMed ID: 24553432
    [Abstract] [Full Text] [Related]

  • 18. Selective albuminuria via podocyte albumin transport in puromycin nephrotic rats is attenuated by an inhibitor of NADPH oxidase.
    Kinugasa S, Tojo A, Sakai T, Tsumura H, Takahashi M, Hirata Y, Fujita T.
    Kidney Int; 2011 Dec 01; 80(12):1328-38. PubMed ID: 21849973
    [Abstract] [Full Text] [Related]

  • 19. Podocyte autophagic activity plays a protective role in renal injury and delays the progression of podocytopathies.
    Zeng C, Fan Y, Wu J, Shi S, Chen Z, Zhong Y, Zhang C, Zen K, Liu Z.
    J Pathol; 2014 Oct 01; 234(2):203-13. PubMed ID: 24870816
    [Abstract] [Full Text] [Related]

  • 20. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
    Fuchshofer R, Ullmann S, Zeilbeck LF, Baumann M, Junglas B, Tamm ER.
    Histochem Cell Biol; 2011 Sep 01; 136(3):301-19. PubMed ID: 21814837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.